[go: up one dir, main page]

TNSN01016A1 - Procede pour la synthese asymetrique de pregabaline - Google Patents

Procede pour la synthese asymetrique de pregabaline

Info

Publication number
TNSN01016A1
TNSN01016A1 TNTNSN01016A TNSN01016A TNSN01016A1 TN SN01016 A1 TNSN01016 A1 TN SN01016A1 TN TNSN01016 A TNTNSN01016 A TN TNSN01016A TN SN01016 A TNSN01016 A TN SN01016A TN SN01016 A1 TNSN01016 A1 TN SN01016A1
Authority
TN
Tunisia
Prior art keywords
pregabaline
asymmetric synthesis
derivative
synthesis
methylhexanoic
Prior art date
Application number
TNTNSN01016A
Other languages
English (en)
Inventor
Joseph Burk Mark
Prakash Goel Om
Simon Hoekstra Marvin
Frederick Mich Thomas
Arthur Mulhern Thomas
Andrew Ramsden James
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26874236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TNSN01016(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of TNSN01016A1 publication Critical patent/TNSN01016A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/23—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same unsaturated acyclic carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L’INVENTION CONCERNE UN PROCEDE POUR LA PREPARATION D’ACIDE (S) - (+) -3-(AMINOMETHYL)-5- METHYLHEXANOIQUE (PREGABALINE). CE PROCEDE COMPREND UNE SYNTHESE PAR HYDROGENATION CATALYTIQUE ASYMETRIQUE. L’INVENTION CONCERNE EGALEMENT LES INTERMEDIAIRES UTILES DANS LA PRODUCTION D’UN TEL DERIVE. APPLICATION : UTILISATION DUDIT DERIVE POUR LE TRAITEMENT ET LA PREVENTION DE TROUBLES CEREBRAUX ET DE LA DOULEUR.
TNTNSN01016A 2000-01-27 2001-01-26 Procede pour la synthese asymetrique de pregabaline TNSN01016A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17835900P 2000-01-27 2000-01-27
US19042700P 2000-03-17 2000-03-17

Publications (1)

Publication Number Publication Date
TNSN01016A1 true TNSN01016A1 (fr) 2005-11-10

Family

ID=26874236

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN01016A TNSN01016A1 (fr) 2000-01-27 2001-01-26 Procede pour la synthese asymetrique de pregabaline

Country Status (50)

Country Link
US (1) US6891059B2 (fr)
EP (1) EP1250311B1 (fr)
JP (2) JP4235384B2 (fr)
KR (1) KR100549748B1 (fr)
CN (1) CN1210253C (fr)
AP (1) AP1438A (fr)
AR (1) AR028499A1 (fr)
AT (1) ATE261930T1 (fr)
AU (1) AU777046B2 (fr)
BG (1) BG65560B1 (fr)
BR (1) BRPI0107863B8 (fr)
CA (1) CA2396090C (fr)
CO (1) CO5251411A1 (fr)
CR (1) CR6703A (fr)
CU (1) CU23221A3 (fr)
CY (1) CY2004011I1 (fr)
CZ (1) CZ302838B6 (fr)
DE (1) DE60102356T2 (fr)
DK (1) DK1250311T3 (fr)
DZ (1) DZ3268A1 (fr)
EA (1) EA004934B1 (fr)
EE (1) EE05216B1 (fr)
EG (1) EG24138A (fr)
ES (1) ES2219493T3 (fr)
GE (1) GEP20043236B (fr)
HN (1) HN2001000010A (fr)
HR (1) HRP20020627B1 (fr)
HU (1) HU228815B1 (fr)
IL (2) IL150633A0 (fr)
IS (1) IS2038B (fr)
MA (1) MA26869A1 (fr)
ME (1) ME00921B (fr)
MX (1) MXPA02007307A (fr)
MY (1) MY127152A (fr)
NO (1) NO327958B1 (fr)
NZ (1) NZ519551A (fr)
OA (1) OA12167A (fr)
PA (1) PA8510501A1 (fr)
PE (1) PE20011063A1 (fr)
PL (1) PL203985B1 (fr)
PT (1) PT1250311E (fr)
RS (1) RS50257B (fr)
SI (1) SI1250311T1 (fr)
SK (1) SK287303B6 (fr)
SV (1) SV2002000295A (fr)
TN (1) TNSN01016A1 (fr)
TR (1) TR200400953T4 (fr)
TW (1) TWI288128B (fr)
UA (1) UA75584C2 (fr)
WO (1) WO2001055090A1 (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU714980B2 (en) 1996-07-24 2000-01-13 Warner-Lambert Company Llc Isobutylgaba and its derivatives for the treatment of pain
RS50257B (sr) * 2000-01-27 2009-07-15 Warner-Lambert Company Llc., Asimetrična sinteza pregabalina
US6687187B2 (en) * 2000-08-11 2004-02-03 Phonak Ag Method for directional location and locating system
EP1543831A1 (fr) * 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Composition de pregabaline
PL1727620T3 (pl) * 2004-03-12 2007-12-31 Warner Lambert Co C1-symetryczne ligandy bifosfin i ich zastosowanie w asymetrycznej syntezie pregabaliny
UA82292C2 (uk) * 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)
HRP20100054T1 (hr) * 2004-06-21 2010-05-31 Warner-Lambert Company Llc Dobivanje pregabalina i njemu sličnih spojeva
WO2006108151A1 (fr) * 2005-04-06 2006-10-12 Teva Pharmaceutical Industries Ltd. Formes cristallines de pregabaline
MX2007012606A (es) * 2005-04-11 2008-01-11 Teva Pharma Proceso para elaborar (s)-pregabalina.
US7488846B2 (en) * 2005-04-11 2009-02-10 Teva Pharmaceuical Industries Ltd. Pregabalin free of lactam and a process for preparation thereof
US7763749B2 (en) * 2005-05-10 2010-07-27 Teva Pharmaceutical Industries Ltd. Method for the preparation of Pregabalin and salts thereof
BRPI0605833A (pt) * 2005-05-10 2007-12-18 Teva Pharma pregabalina livre de ácido isobutilglutárico e um processo para sua preparação
EP1879854B1 (fr) * 2005-05-10 2011-09-07 Teva Pharmaceutical Industries Ltd Resolution optique de l'acide 3-carbamoylmethyl-5-methyl hexanoique
US20060270871A1 (en) * 2005-05-30 2006-11-30 Khanduri Chandra H Polymorphic form i of pregabalin and processes for its preparation
CN100410242C (zh) * 2005-06-23 2008-08-13 江苏恩华药业股份有限公司 普瑞巴林中间体及其制备方法
ES2398579T3 (es) * 2005-09-19 2013-03-20 Teva Pharmaceutical Industries Ltd Una síntesis asimétrica de ácido (S)-(+)-3-(aminometil)-5-metilhexanoico
NL2000281C2 (nl) 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
KR20080016658A (ko) * 2006-04-24 2008-02-21 테바 파마슈티컬 인더스트리즈 리미티드 3-이소부틸글루타르산의 합성 방법
WO2007139933A2 (fr) * 2006-05-24 2007-12-06 Teva Pharmaceutical Industries Ltd. Procédés pour la préparation d'acide r-(+)-3-(carbamoyl méthyl)-5-méthylhexanoïque et de sels de celui-ci
EP2071032A3 (fr) * 2006-05-31 2009-07-08 Teva Pharmaceutical Industries Ltd Utilisation d'une résolution enzymatique pour la préparation d'intermédiaires de la prégabaline
EP1912931A2 (fr) * 2006-05-31 2008-04-23 Teva Pharmaceutical Industries Ltd. Préparation de (s)-prégabaline nitrile
EP1903027A1 (fr) * 2006-09-13 2008-03-26 Novartis AG Procédé de préparation de l' acide amino-4 butyrique ou de ses derivés et leur utilisation pour la préparation des inhibiteurs NEP
KR101036536B1 (ko) 2007-03-22 2011-05-24 테바 파마슈티컬 인더스트리즈 리미티드 (ｓ)-(+)-3-(아미노메틸)-5-메틸 헥산산의 합성
US8168828B2 (en) 2007-06-25 2012-05-01 Msn Laboratories, Limited Process for the preparation of pregabalin
KR100846419B1 (ko) * 2007-08-10 2008-07-15 한국과학기술원 프레가발린의 신규한 제조 방법
US20090137842A1 (en) * 2007-10-03 2009-05-28 Vollerner Yuri Pregabalin -4-eliminate, pregabalin 5-eliminate, their use as reference marker and standard, and method to produce pregabalin containing low levels thereof
EP2053040A1 (fr) * 2007-10-26 2009-04-29 Chemo Ibérica, S.A. Intermédiaires de la Prégabaline et leurs procédés de préparation et Prégabaline
WO2009087674A2 (fr) * 2007-12-18 2009-07-16 Watson Pharma Private Limited Procédé perfectionné pour la préparation de (s)-prégabaline
EP2222630A1 (fr) * 2007-12-26 2010-09-01 Generics (UK) Limited Procédés de préparation de la prégabaline
AU2008345851B2 (en) * 2008-01-10 2012-08-16 Sumitomo Chemical Company, Limited Method for producing cyclopropane carboxylic acid compound and intermediate therefor
EP2110372A1 (fr) 2008-04-16 2009-10-21 Chemo Ibérica, S.A. Intermédiaires pour la préparation de prégabaline et leur procédé de préparation
JP2010043063A (ja) 2008-05-09 2010-02-25 Agency For Science Technology & Research 川崎病の診断及び治療
CN102099482B (zh) 2008-05-21 2014-04-16 桑多斯股份公司 5-甲基-3-硝基甲基-己酸酯的立体选择性酶水解方法
WO2009158343A1 (fr) * 2008-06-23 2009-12-30 Teva Pharmaceutical Industries, Ltd. Synthèse enzymatique stéréosélective de l’ester (s) ou (r)-isobutylglutarique
WO2010070593A2 (fr) 2008-12-19 2010-06-24 Pfizer Ireland Pharmaceuticals Esters de malonate
CN101987826A (zh) * 2009-08-04 2011-03-23 铜陵凯顺生物科技有限公司 一种(3s)-3-氨甲基-5-甲基己酸的合成方法
WO2011141923A2 (fr) 2010-05-14 2011-11-17 Lupin Limited Synthèse améliorée d'un ester alkylique optiquement pur de l'acide (s) - 3-cyano-5-méthyl-hexanoïque, intermédiaire de la (s)-prégabaline
US8212072B2 (en) 2010-08-13 2012-07-03 Divi's Laboratories, Ltd. Process for the preparation of pregabalin
WO2012025861A1 (fr) 2010-08-23 2012-03-01 Pfizer Manufacturing Ireland Procédé de préparation de dérivés d'acide (s)-3-cyano-5-méthylhexanoïque et de prégabaline
CN102464594B (zh) * 2010-11-17 2014-06-25 凯瑞斯德生化(苏州)有限公司 普瑞巴林的中间体化合物的制备方法
WO2014181359A1 (fr) 2013-05-09 2014-11-13 Council Of Scientific & Industrial Research Procédé pour la préparation d'un agent anticonvulsivant : le chlorhydrate de prégabaline
WO2016075082A1 (fr) 2014-11-10 2016-05-19 Sandoz Ag Amination réductrice stéréosélective d'aldéhydes alpha-chiraux au moyen d'ω-transaminases pour la synthèse de précurseurs de la prégabaline et du brivaracétam
WO2017019791A1 (fr) 2015-07-27 2017-02-02 Teva Pharmaceuticals International Gmbh Synthèse de (s)-prégabaline

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS588390B2 (ja) * 1978-05-23 1983-02-15 住友化学工業株式会社 光学活性ω↓−シアノ↓−α↓−アシルアミノ酸誘導体の製造法
US4939288A (en) * 1989-01-23 1990-07-03 Monsanto Company Method of preparing (R)-succinic acid derivatives
US6197819B1 (en) 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
US5171892A (en) 1991-07-02 1992-12-15 E. I. Du Pont De Nemours And Company Chiral phospholanes via chiral 1,4-diol cyclic sulfates
US5616793A (en) * 1995-06-02 1997-04-01 Warner-Lambert Company Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid
US5637767A (en) * 1995-06-07 1997-06-10 Warner-Lambert Company Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
US5840965A (en) * 1996-06-24 1998-11-24 E. I. Du Pont De Nemours And Company Process for the production of purified telephthalic acid
AU714980B2 (en) 1996-07-24 2000-01-13 Warner-Lambert Company Llc Isobutylgaba and its derivatives for the treatment of pain
US6127418A (en) 1997-08-20 2000-10-03 Warner-Lambert Company GABA analogs to prevent and treat gastrointestinal damage
CA2309668A1 (fr) 1997-12-17 1999-06-24 Chirotech Technology Limited Hydrogenation asymetrique
WO1999052852A1 (fr) 1998-04-09 1999-10-21 Chirotech Technology Limited Hydrogenation asymetrique
RS50257B (sr) * 2000-01-27 2009-07-15 Warner-Lambert Company Llc., Asimetrična sinteza pregabalina

Also Published As

Publication number Publication date
CR6703A (es) 2003-06-24
HUP0204307A2 (hu) 2003-06-28
HUP0204307A3 (en) 2003-07-28
BG65560B1 (bg) 2008-12-30
CN1210253C (zh) 2005-07-13
EA200200642A1 (ru) 2002-12-26
KR100549748B1 (ko) 2006-02-08
SI1250311T1 (en) 2004-10-31
NO327958B1 (no) 2009-10-26
EP1250311B1 (fr) 2004-03-17
NO20023582D0 (no) 2002-07-26
DE60102356T2 (de) 2005-02-17
JP2009073841A (ja) 2009-04-09
PA8510501A1 (es) 2002-02-21
GEP20043236B (en) 2004-05-25
WO2001055090A1 (fr) 2001-08-02
JP4235384B2 (ja) 2009-03-11
CZ20022520A3 (cs) 2002-10-16
AR028499A1 (es) 2003-05-14
HU228815B1 (en) 2013-05-28
SK10782002A3 (sk) 2002-11-06
CY2004011I1 (el) 2010-07-28
NO20023582L (no) 2002-09-02
CU23221A3 (es) 2007-07-20
TR200400953T4 (tr) 2004-07-21
MA26869A1 (fr) 2004-12-20
EP1250311A1 (fr) 2002-10-23
KR20020073187A (ko) 2002-09-19
YU56202A (sh) 2006-01-16
PL357077A1 (en) 2004-07-12
IL150633A (en) 2009-08-03
SV2002000295A (es) 2002-06-07
SK287303B6 (sk) 2010-06-07
HN2001000010A (es) 2001-06-13
EA004934B1 (ru) 2004-10-28
JP2003520841A (ja) 2003-07-08
ATE261930T1 (de) 2004-04-15
IL150633A0 (en) 2003-02-12
TWI288128B (en) 2007-10-11
PE20011063A1 (es) 2001-10-18
HRP20020627A2 (en) 2004-08-31
AP1438A (en) 2005-05-23
OA12167A (en) 2006-05-08
DK1250311T3 (da) 2004-08-16
CA2396090A1 (fr) 2001-08-02
AU777046B2 (en) 2004-09-30
IS2038B (is) 2005-08-15
BRPI0107863B8 (pt) 2017-04-25
EE200200403A (et) 2003-10-15
US20030212290A1 (en) 2003-11-13
CZ302838B6 (cs) 2011-12-07
MXPA02007307A (es) 2002-11-29
EE05216B1 (et) 2009-10-15
HRP20020627B1 (hr) 2011-01-31
IS6430A (is) 2002-06-19
AU2213801A (en) 2001-08-07
US6891059B2 (en) 2005-05-10
PL203985B1 (pl) 2009-11-30
CO5251411A1 (es) 2003-02-28
BR0107863B1 (pt) 2013-06-18
DE60102356D1 (de) 2004-04-22
EG24138A (en) 2008-08-06
PT1250311E (pt) 2004-07-30
UA75584C2 (uk) 2006-05-15
CN1396905A (zh) 2003-02-12
NZ519551A (en) 2004-02-27
DZ3268A1 (fr) 2001-08-02
AP2002002588A0 (en) 2002-09-30
ME00921B (me) 2012-06-20
BR0107863A (pt) 2002-11-05
BG106849A (en) 2003-03-31
CA2396090C (fr) 2006-01-10
RS50257B (sr) 2009-07-15
ES2219493T3 (es) 2004-12-01
JP4886753B2 (ja) 2012-02-29
MY127152A (en) 2006-11-30

Similar Documents

Publication Publication Date Title
TNSN01016A1 (fr) Procede pour la synthese asymetrique de pregabaline
DE69330949T2 (de) Gaba und l-glutaminsaüre analoga zur behandlung der epilepsie
TNSN99039A1 (fr) Bicyclo [2.2.1] heptanes nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98025A1 (fr) Derives d'acide arylsulfonylhydroxamique, procede pour leur preparation et compositions les contenant.
TNSN98036A1 (fr) Derives d'acide hexanoique nouveaux
TNSN98019A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN00036A1 (fr) Acides oxamiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98150A1 (fr) Derives d'acides aryloxyarylsulfonylaminohydroxamiques ; procede pour leur preparation et compositions pharmaceutiques les contenant
CA2304965A1 (fr) Derives de l'acide ((cyclo)alkyl substitue)-gamma-aminobutyrique (=gaba analogues), leur preparation et utilisation dans le traitement de desordres neurologiques
CA2322558A1 (fr) Composes d'acide amines soumis a une contrainte de conformation et presentant une affinite pour la sous-unite alpha 2 delta d'un canal calcique
TNSN99031A1 (fr) Composes heterocycliques nouveaux inhibiteurs de romatases, procede pour leur preparation et compositions pharmaceutiques les contenant
NO20004432L (no) Glysintransportinhibitorer
YU73004A (sh) Biciklične amino kiseline kao farmaceutska sredstva
TNSN99106A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99147A1 (fr) Procede d'emulsification
EA200101134A1 (ru) Одно- и двузамещенные 3-пропил-гамма-аминомасляные кислоты
TNSN98024A1 (fr) 2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN88096A1 (fr) Nouveau n-(1-alkyl-3-hydroxy-4-piperidyl)
TNSN01167A1 (fr) Formes de sels d'amide d'acide 3-(4-bromo-2,6-difluoro-benzyloxy) - 5 [3 - (4 - pyrrolidine - 1 - yl - butyl) ureido] isothiazole - 4 - carboxylique, et procede pour leur production.
TNSN96153A1 (fr) Procedes et intermediaires pour la preparation de 1-benzyl-4 ((5,6 -dimethoxy-1-indanone)-2- yl) methylpiperidine.
TNSN98127A1 (fr) Derives d'azetidinylpropylpiperidine , procede pour leur preparation et compositions pharmaceutiques les contenant.
EP0876149A4 (fr) Procede de traitement des troubles caracterises par une surexpression de la cytidine-desaminase ou de la desoxycytidine-desaminase
TNSN99013A1 (fr) Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN00106A1 (fr) Composition pharmaceutique nouvelle comprenant un inhibiteur de nos, et procede pour sa preparation
TNSN97143A1 (fr) Derives de trans-piperazine-1-yl-spiro(cyclohexane-1, 1'- isobenzofuranne), procede pour leur preparation et compositions pharmaceutiques les contenant